Gevo, Inc.
NASDAQ:GEVOChemicals - Specialty
+$0.04 today
- Market cap
- $420.54M
- Beta
- 0.99
- P/E (TTM)
- -10.7
- EPS (TTM)
- -$0.14
Volume 2.74M
Average 3.88M
GEVO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Gevo, Inc.NASDAQ: GEVO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development growth accelerates
Q1 FY2026 research & development of $4.54M rose 331.5% year over year, ahead of the +195.4% change in trailing-twelve-month research & development. Sequentially, it rose 16.9% from the prior quarter. Over 3 fiscal years it compounded at -36.2% a year.
Context
- Research & development amounted to 2.8% of revenue in FY2025, down 137.5 pp from a year earlier.
- Research & development increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +331.5% holds above the trailing-twelve-month pace of +195.4%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 4.55M USD
- Year-over-year change
- -80.8%
- 4-year CAGR
- -28.4%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.55M | -80.8% |
| FY2024 | 2024-12-31 | 23.74M | +257.7% |
| FY2023 | 2023-12-31 | 6.64M | -62.0% |
| FY2022 | 2022-12-31 | 17.49M | +0.8% |
| FY2021 | 2021-12-31 | 17.36M | — |
Research & Development vs competitors
How GEVO compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +195.4% is the highest of 7, against a peer median of -61.1%.
- Research & development amounts to 6.1% of revenue for GEVO, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $22.8M USD | -2.1% | +7.9% | 1.2% | |
| LTM Mar 2026 | $11.89M USD | -22.2% | -3.5% | 4891.2% | |
| LTM Mar 2026 | $10.63M USD | +195.4% | -36.2% | 6.1% | |
ADURAduro Clean Technologies Inc. | LTM Feb 2026 | CA$7.36M CAD | +38.8% | +73.9% | 3044.1% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | +7.7% | 0.0% | |
| Peer median (excluding GEVO) | — | -61.1% | +7.8% | 0.0% | |
Competitors are the stored peer set for GEVO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 533K | 1.18M | 17.2M | 16.92M | 160.58M |
| Cost of Revenue | 7.69M | 8.7M | 11.99M | 12M | 112.04M |
| Gross Profit | (7.15M) | (7.52M) | 5.21M | 4.91M | 48.54M |
| Gross Margin | -1342.2% | -640.3% | 30.3% | 29.0% | 30.2% |
| Research & Development | 17.36M | 17.49M | 6.64M | 23.74M | 4.55M |
| Selling, General & Admin | 25.49M | 39.94M | 42.63M | 45.8M | 51.2M |
| Operating Expenses | 53.11M | 95.16M | 87.04M | 95.74M | 67.41M |
| Depreciation & Amortization | 5.13M | 7.89M | 19.01M | 18.3M | 25.32M |
| EBITDA | (53.82M) | (88.95M) | (45.05M) | (56.46M) | 10.25M |
| EBITDA Margin | -10098.3% | -7570.5% | -261.9% | -333.8% | 6.4% |
| Operating Income | (60.27M) | (102.69M) | (81.84M) | (90.82M) | (18.87M) |
| Operating Margin | -11307.3% | -8739.2% | -475.8% | -536.9% | -11.7% |
| Interest Income | 571K | 3.48M | 19.09M | 15.74M | 7.81M |
| Interest Expense | 251K | 1.17M | 2.16M | 3.88M | 17.56M |
| Other Income / Expenses | 1.07M | 4.68M | 15.62M | 12.18M | (13.76M) |
| Income Before Tax | (59.2M) | (98.01M) | (66.22M) | (78.64M) | (32.63M) |
| Pre-Tax Margin | -11107.5% | -8341.0% | -385.0% | -464.9% | -20.3% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (59.2M) | (98.01M) | (66.22M) | (78.64M) | (33.84M) |
| Net Margin | -11107.5% | -8341.0% | -385.0% | -464.9% | -21.1% |
| EPS (Basic) | (0.30) | (0.44) | (0.28) | (0.34) | (0.14) |
| EPS (Diluted) | (0.30) | (0.44) | (0.28) | (0.34) | (0.14) |
| Weighted Avg Shares | 195.79M | 221.54M | 238.69M | 231.67M | 234.01M |
| Weighted Avg Shares (Diluted) | 195.79M | 221.54M | 238.69M | 231.67M | 234.01M |
Gevo, Inc.
NASDAQ:GEVO
Intrinsic Alpha fair value
Locked
Current Price
$1.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.